Morepen Laboratories Limited, established in 1984, is a prominent Indian pharmaceutical company specializing in manufacturing and marketing a diverse range of products, including APIs like Loratadine and Montelukast Sodium, and formulations in therapeutic areas such as antibiotics, gastrointestinal, and respiratory. The company operates three advanced manufacturing facilities in Himachal Pradesh, with the Parwanoo plant being USFDA-approved for Loratadine production. Morepen has expanded its offerings with notable brands like Saltum, Montelast, and Dr. Morepen OTC formulations.
The company has a strong focus on innovation, having filed 14 patents, including international applications, and developed a new form of Lipitor. Strategic partnerships and joint ventures, such as with DiaMed AG, have enhanced its market reach. Morepen has also diversified into diagnostics and personal care, launching divisions and products like the Cardia Division for diabetic and cardiac care, and GUBB USA for grooming. In 2023, it expanded into health monitoring devices and immunity-boosting products.
